Latest at Cipla

Therapies at Cipla
With our growing scientific understanding of rare diseases, we shall continue to introduce ground breaking therapies to give our patients their new beginnings!
From Care to Cure
Life at Cipla
Investor Centre
Stock Price Index
Turnover
$2.5 Billion
Latest Press Releases
Investor Resources
Employee stories
Hear it from the Cipla-ites!

César Useros Cubo
Cipla Europe, Spain

Cipla bags the first prize in the GOQii Corporate Challenge at an organisational level. Kudos to the commitment and dedication of Ciplaites who prioritise their physical well-being by accommodating fitness in their lifestyle! https://t.co/2rjDX0ZwEV

Cracker of a webinar on Scaling AMR InnovationsTakeaways:- Pull mechanisms critical for availability & access - Build partnerships for commercialisation early - Access & excess both problems in AMR- Pricing strategy is key. Consider minimum instead of maximum price@CARB_X https://t.co/YsPeMSPAG3 https://t.co/trIzvl1M3Y

Cautionary Note: There are a few phishing & malicious websites inviting visitors to complete a questionnaire and a chance to win money. Please note that this is a scam. Neither Cipla nor any of its subsidiaries are associated with this scheme or any of the websites. https://t.co/rmWuvAD8AT

Cipla scores highest among pharma companies in CRISIL's Sustainability Rating 2022Read more - https://t.co/xeDPACEZgE https://t.co/D9fFjI4Fcl